skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8830

A case of unilateral optic disc swelling with chronic active Epstein–Barr virus infection

Case report

(1929) Views  (577) Full article downloads

Authors: Naoko Aizawa, Toru Nakazawa, Masahiko Shimura

Published Date August 2010 Volume 2010:4 Pages 977 - 979
DOI: http://dx.doi.org/10.2147/OPTH.S13048

Naoko Aizawa1, Toru Nakazawa1, Masahiko Shimura2

1Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan; 2Department of Ophthalmology, NTT East Japan Tohoku Hospital, Sendai, Miyagi, Japan

Abstract: Ocular complications of chronic active Epstein–Barr virus (EBV) infection have rarely been reported and are usually associated with systemic symptoms. We described a 17-year-old boy with unilateral optic disc swelling without any systemic symptoms at the initial onset. Antibody titers to EBV were markedly elevated. Treatment with immunosuppressants and corticosteroids dramatically relieved all his symptoms, including unilateral optic swelling and visual field abnormalities.

Keywords: Epstein–Barr virus, optic disk swelling






Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
ABO and rhesus blood group distribution in Kurds
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
The role of clinical parapapillary atrophy evaluation in the diagnosis of open angle glaucoma
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy